The markets saw a modest rebound Thursday as this sideways, choppy trend continues. The Nasdaq was the leader up 38 (0.86%) as Facebook blew away investors with their earnings report. Yesterday the Nasdaq lost ground as Apple disappointed but today Facebook supported the tech heavy market. As we have mentioned in the past, this type of market activity is common during earnings season and will settle soon. The S&P 500 had a nice day as well posting an 10 point gain (0.54%), and the Dow put up 123 points (0.78%). Facebook(NASDAQ: FB) shares took off today following an impressive earnings release. The social media leader beat all of the streets expectation's and managed to finish up a whopping 15.52%. This move goes down as one of the biggest one day moves ever for Facebook. The company reported nearly 1.6 billion monthly, active users which means roughly 1 in 7 people on the planet are using the platform. The company also noted that the majority of users are now on mobile.
The biotech sector wishes it didn't wake up today as the biotech ETF (NYSE: IBB) was pummeled today losing 3.66% thanks to Celgene (NASDAQ: CELG). Celgene makes up almost 8% of the IBB and after reporting earnings today lost 4.98%. The company also recently shook up its management, naming a new chief executive, and made efforts to broaden its reach beyond drugs to treat multiple myeloma. Investors are clearly not happy with the company's moves as shares fell to a new 52 week low today.
Lastly Investors were more than excited by the fourth-quarter results from Under Armour (NYSE: UA). The stock went crazy after the company reported a huge surge in profit and revenue, and offered a better-than-expected outlook going forward. Special note: A big driver of the company's recent success is NBA star Steph Curry. Footwear sales shot up 95% in the quarter, thanks in part to Curry's signature basketball shoe line. Under Armour finished the day up 22.59%.